Français
ItalianoBond Bausch Health Companies 6.25% ( US071734AK34 ) in USD
| Issuer | Bausch Health Companies | ||||||
| Market price |  78.43 % ▲ |
||||||
| Country |  Canada
|
||||||
| ISIN code |
 US071734AK34 ( in USD )
|
||||||
| Interest rate | 6.25% per year ( payment 2 times a year) | ||||||
| Maturity | 15/02/2029 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 1 500 000 000 USD | ||||||
| Cusip | 071734AK3 | ||||||
| Standard & Poor's ( S&P ) rating | CCC+ ( Substantial risks ) | ||||||
| Moody's rating | Ca ( Default imminent with little prospect for recovery ) | ||||||
| Next Coupon | 15/02/2027 ( In 173 days ) | ||||||
| Detailed description |
Bausch Health Companies is a global pharmaceutical company focused on developing, manufacturing, and marketing a range of pharmaceutical, ophthalmological, and consumer healthcare products. The Bond issued by Bausch Health Companies ( Canada ) , in USD, with the ISIN code US071734AK34, pays a coupon of 6.25% per year. The coupons are paid 2 times per year and the Bond maturity is 15/02/2029 The Bond issued by Bausch Health Companies ( Canada ) , in USD, with the ISIN code US071734AK34, was rated Ca ( Default imminent with little prospect for recovery ) by Moody's credit rating agency. The Bond issued by Bausch Health Companies ( Canada ) , in USD, with the ISIN code US071734AK34, was rated CCC+ ( Substantial risks ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||